US Incidence of Distant-Stage Prostate Cancer Up, 2010 to 2017
Five-year survival for distant-stage prostate cancer improved from 2011 to 2016.
NEWS
LATEST NEWS
Understanding the Stigma Experienced by Patients With Prostate Cancer
Interview study reveals men’s perception and concerns related to their prostate cancer journey.
MACE Up for High-Risk Patients After Noncardiac Surgery
Incidence of MACE 20.6% within 365 days in patients at increased CV risk.
Pegloticase in Combination With Methotrexate Improves Therapeutic Response in Uncontrolled Gout
Researchers examined the efficacy and safety of pegloticase in combination with methotrexate in patients with uncontrolled gout.
Alpha Blockers Linked to Higher Risk for Kidney Disease Progression
New findings could allow clinicians to have more nuanced discussions with patients who have chronic kidney disease regarding the long-term risks associated with alpha blocker use to control blood pressure.
Ertugliflozin Noninferior for CV Outcomes in T2DM With ASCVD
Ertugliflozin is noninferior to placebo for the primary end point of major adverse cardiovascular events.
Removal Plus Transplant Surgery Feasible in Polycystic Kidney Disease
Simultaneous bilateral laparoscopic nephrectomy can be done at the time of living donor kidney transplant
Gout May Not Be Associated With Cardiovascular Complications in Peripheral Artery Disease
Gout was not found to be associated with increased risk for cardiovascular complications in patients with peripheral artery disease.
Color-Coded Dual-Energy CT Lesions Show Heterogeneity in Properties and Distribution in Gout
Researchers evaluated the properties and locations of color-coded dual-energy lesions in patients with gout.
Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Prostate Cancer
